Schedule

• Session details will be available soon

• Best practices when negotiating a CIA
• Preparing for the "New Normal"–establishing an effective support system by engaging governance, counsel, and executive leadership
• Feedback from the OIG Monitor and the CIA mandated Compliance Expert to educate leadership and clinicians on the importance of an effective compliance program
• Using the CIA as an opportunity to enhance business practices by improving operational efficiency and shared accountability for compliance and ethics
• Keys to aligning long-term business strategies with compliance goals

This session will deliver practical advice from an experienced panel on the “dos and don’ts” of responding to government enforcement agency inquiries. Avoiding missteps in the response to a government inquiry is critical to minimize the impact on the organization's operations. This session will address the following scenarios:

• Government agents seeking voluntary interviews with current or former employees, vendors, and/or patients
• DOJ or other federal agencies asking an organization to respond to specific allegations or to conduct a self-audit
• CID(s) issued when the organization may or may not be the target of the government agency's investigation
• Grand jury subpoenas directed to the organization or third parties seeking information related to the organization
• Execution of search warrants at a corporate office or facility

This session will not be available on the live virtual agenda.Virtual attendees will have access to the recording.

• The changes to CMS and OIG guidance on use of sampling and extrapolation for self-auditing
• Key challenges to raise in defending an extrapolated overpayment in contractual and administrative appeals
• The changes in federal law as a result of current litigation on government payors
• How generative artificial intelligence (gAI) is anticipated to impact the use of sampling and extrapolation and potential challenges to the evidence that gAI programs produce in reimbursement disputes

• HIPAA Administrative Transactions
• Adoption of Standards
• Complaint Adjudication Process
• Compliance Review Process
• Complaint Submission Portal/Testing Tool

• Session details will be available soon

• Session details will be available soon

• What is AI?
• Why do we care?
• How is AI affecting the practice of law?
  • Discovery, document review, contract analysis and due diligence
  • Legal document generation
• How will AI affect our clients? How are healthcare stakeholders using AI?
• Ethical issues
  • Rules and formal ethics opinions

• The basics of procedural (CPT) and diagnosis (ICD-10) coding for Professional Services
• General guidance on use of the CPT & ICD coding manuals
• The basics of ICD-10-CM and ICD-10-PCS for Facility Services
• Hospital Billing Rules and Payment Systems

This session will not be available on the live virtual agenda.Virtual attendees will have access to the recording.

• Session details will be available soon

• Session details will be available soon

• Session details will be available soon

• Session details will be available soon

• Session details will be available soon

This session will cover key Fraud and Abuse developments over the past year. Highlights include:

• Enforcement trends under the Trump Administration
• The Government’s increased focus on Managed Care Fraud
• False Claims Act case law and settlements
• New Compliance Guidance
• Stark and Anti-kickback developments
• Reimbursement rollercoaster– Medicaid cuts, 340B, coding changes, shifts in payment policy

This session will not be available on the live virtual agenda.Virtual attendees will have access to the recording.

• Recent enforcement trends and False Claims Act litigation against clinical laboratories, remote patient monitoring providers, and durable medical equipment suppliers
• How do recent cases and the administration’s enforcement priorities impact DOJ’s approach to FCA cases, and the opportunities recent case law provide the defense bar
• Potential pitfalls for the unwary and how can practitioners avoid them
• The trends the defense bar, regulatory counsel, and the Government have observed over the past year

• Session details will be available soon

This session will deliver practical advice from an experienced panel on the “dos and don’ts” of responding to government enforcement agency inquiries. Avoiding missteps in the response to a government inquiry is critical to minimize the impact on the organization's operations. This session will address the following scenarios:

• Government agents seeking voluntary interviews with current or former employees, vendors, and/or patients
• DOJ or other federal agencies asking an organization to respond to specific allegations or to conduct a self-audit
• CID(s) issued when the organization may or may not be the target of the government agency's investigation
• Grand jury subpoenas directed to the organization or third parties seeking information related to the organization
• Execution of search warrants at a corporate office or facility

• Session details will be available soon

• Using hypotheticals, this interactive presentation will consider some common mistakes encountered in physician self-referral law (PSL) analysis
• This intermediate session will focus on certain elements of the PSL that can cause confusion when analyzing an arrangement or submitting s self-disclosure under the SRDP
• The presenters will walk through the process of applying each element of the PSL to real-world scenarios that can result in problematic analysis when an element is skipped or applied incorrectly

This session will not be available on the live virtual agenda.Virtual attendees will have access to the recording.

• Session details will be available soon

• Session details will be available soon

• Session details will be available soon

This session will not be available on the live virtual agenda.Virtual attendees will have access to the recording.

• Foundational and emerging regulatory frameworks impacting behavioral health, including federal and state laws, recent updates, and enforcement priorities
• New legal developments and evolving standards around privacy, consent, telehealth, and technology (AI) adoption with guidance on risk mitigation and compliance integration
• Essential elements of effective compliance programs and tailored best practices for behavioral health providers
• Real-world case examples to illustrate compliance challenges, solutions, and lessons learned, and provide strategies for future readiness and adaptability

This session will not be available on the live virtual agenda.Virtual attendees will have access to the recording.

• Session details will be available soon

The health care industry thrives on data. This data–most of it about people–is heavily regulated. We have known about HIPAA for many years. Recently, however, the field is growing even more complicated. Companies must deal with law in and out of HIPAA. What's out of HIPAA is growing enormously. How we define "health information" is changing regularly. And a new range of laws–mostly at the state level–are creating new challenges and complexity and confusion for health care companies or any companies that use health care data. This session will explore this growing complexity and identify some of the most substantial compliance challenges that are emerging.

• What is AI?
• Why do we care?
• How is AI affecting the practice of law?
  • Discovery, document review, contract analysis and due diligence
  • Legal document generation
• How will AI affect our clients? How are healthcare stakeholders using AI?
• Ethical issues
  • Rules and formal ethics opinions

• Session details will be available soon

This session will not be available on the live virtual agenda.Virtual attendees will have access to the recording.

• The changes to CMS and OIG guidance on use of sampling and extrapolation for self-auditing
• Key challenges to raise in defending an extrapolated overpayment in contractual and administrative appeals
• The changes in federal law as a result of current litigation on government payors
• How generative artificial intelligence (gAI) is anticipated to impact the use of sampling and extrapolation and potential challenges to the evidence that gAI programs produce in reimbursement disputes

• Session details will be available soon

• Session details will be available soon

• Session details will be available soon

• Session details will be available soon

• Session details will be available soon

This session will not be available on the live virtual agenda.Virtual attendees will have access to the recording.

• Session details will be available soon

• Session details will be available soon

• Session details will be available soon

• Session details will be available soon

The health care industry thrives on data. This data–most of it about people–is heavily regulated. We have known about HIPAA for many years. Recently, however, the field is growing even more complicated. Companies must deal with law in and out of HIPAA. What's out of HIPAA is growing enormously. How we define "health information" is changing regularly. And a new range of laws–mostly at the state level–are creating new challenges and complexity and confusion for health care companies or any companies that use health care data. This session will explore this growing complexity and identify some of the most substantial compliance challenges that are emerging.